accounts biggest seller of heart stents, reported adjusted profit that topped analysts' estimates on sales of its new medical devices. Income excluding certain items was 19 cents a share, the Natick, Mass., company said in a statement. That beat by 7 cents the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Scientific profits top estimates
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
